Related Experiment Video
Updated: Jun 28, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Liver Disease-Associated Glomerulopathies
Swetha R Kanduri1, Yonatan Peleg2, Shikha Wadhwani2
1Department of Nephrology, Ochsner Health System, New Orleans, LA; Ochsner Clinical School, The University of Queensland, New Orleans, LA.
Insights
Hepatitis B (HBV) and C (HCV) viruses can cause kidney disease, including IgA nephropathy. Antiviral therapy is the primary treatment for HBV- and HCV-related glomerulonephritis, improving outcomes.
Area of Science:
- Nephrology
- Hepatology
- Virology
Background:
- Hepatitis B virus (HBV) and hepatitis C virus (HCV) cause global health issues.
- Extra-hepatic manifestations, such as glomerular disease, are recognized complications.
- Liver disease-associated IgA nephropathy is a leading cause of secondary IgA nephropathy.
Purpose of the Study:
- To review epidemiology, pathogenesis, clinical features, and treatment of HBV- and HCV-related glomerulonephritis.
- To discuss IgA nephropathy in patients with liver disease.
- To provide an updated perspective on these kidney diseases.
Main Methods:
- Literature review of HBV- and HCV-related glomerulonephritis.
- Analysis of IgA nephropathy associated with liver disease.
- Synthesis of current knowledge on pathogenesis and treatment.
Main Results:
- Membranous nephropathy is common in HBV-related glomerulonephritis; others include MPGN and podocytopathies.
- HCV-related glomerulonephritis often presents as cryoglobulinemic glomerulonephritis.
- Antiviral therapy, especially direct-acting antivirals, has improved HBV-GN and HCV-GN outcomes.
Conclusions:
- Antiviral therapy is the cornerstone for treating HBV- and HCV-related glomerulonephritis.
- Immunosuppression (e.g., anti-CD20) may be used for severe or aggressive cases.
- Understanding these viral-associated kidney diseases is crucial for patient management.
Abstract:
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infect a significant number of individuals globally and their extra-hepatic manifestations, including glomerular disease, are well established. Additionally, liver disease-associated IgA nephropathy is the leading cause of secondary IgA nephropathy with disease course varying from asymptomatic urinary abnormalities to progressive kidney injury. Herein we provide an updated review on the epidemiology, pathogenesis, clinical manifestations, and treatment of HBV- and HCV-related glomerulonephritis as well as IgA nephropathy in patients with liver disease. The most common HBV-related glomerulonephritis is membranous nephropathy, although membranoproliferative glomerulonephritis and podocytopathies have been described. The best described HCV-related glomerulonephritis is cryoglobulinemic glomerulonephritis occurring in about 30% of patients with mixed cryoglobulinemic vasculitis. The mainstay of treatment for HBV-GN and HCV-GN is antiviral therapy, with significant improvement in outcomes since the emergence of the direct-acting antivirals. However, cases with severe pathology and/or a more aggressive disease trajectory can be offered a course of immunosuppression, commonly anti-CD20 therapy, particularly in the case of cryoglobulinemic glomerulonephritis.
More Related Videos
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrons
Lysosomal Hydrolases
Proteoglycans
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

